Extensive Psilocybin Trial Shows Great Promise for Treating Serious Depression
Although Small Number Serious Adverse Events Were Reported SafeMinds Shares has reported previously on psilocybin, a hallucinogenic/psychedelic substance that works by activating serotonin receptors in the prefrontal cortex, the area of the brain that affects mood, cognition, and perception. Early trials have shown that the psychedelic holds promise as an autism treatment since it supports […]
Study Claims Microbiome Not a Causal Factor in Autism Spectrum Disorder
Research Suggests that Picky Eating Causes Differences in Gut Bacteria A bold new Australian study asserts that gut health “is no way a cause of why the brain develops differently” in individuals with autism. The researchers involved in this effort claim that previous studies linking microbiome contents to autism have been underpowered and not designed […]
Brain Stimulation Protocol Results in Remission of Depression for 79% of Patients
Non-Invasive Treatment Produced No Adverse Events During Clinical Trial Research has shown that individuals with autism are 4-times more likely to experience depression over their lifetime compared to people without the disorder. Due to this fact, a recently released placebo-controlled test out of Stanford University’s Medical Center should be very interesting to the autism community. […]
Strengths and Abilities Exhibited by Individuals with ASD in the Workplace
A recent survey out of the United Kingdom’s Office of National Statistics found that just 22% of adults on the spectrum held any type of paying job. Unfortunately, the situation is not better in the United States, where the unemployment rate for people with autism is 85%.
Visual Mental Representations in Adults with Autism
Recent research from France has investigated the use of visual mental representation, sometimes described as “thinking in pictures,” in adults with autism.
Pilot Study Suggests Normal Fungi Levels in Children with ASD
A new pilot study has examined the levels of candida species (a type of fungi) in children with autism spectrum disorder. The study’s authors stated that they were compelled to research this topic due to the limited evidence which indicates that candida is more prevalent in children with ASD.
